Home
Home

Procrit

Is Johnson & Johnson Heading Off The Patent Cliff?

Is Johnson & Johnson Heading Off The Patent Cliff?
Seeking Alpha

EPO Pills: A Challenge For Amgen And Johnson & Johnson

EPO Pills: A Challenge For Amgen And Johnson & Johnson
Seeking Alpha

FDA recommends lower doses of anemia drugs

FDA recommends lower doses of anemia drugs
Yahoo/AP

Amgen, J&J Anemia Drugs Won’t Face New U.S. Coverage Policy

Amgen, J&J Anemia Drugs Won’t Face New U.S. Coverage Policy
Bloomberg

Amgen’s Epogen, J&J’s Procrit Boost Heart Attack Patients’ Risk

Amgen’s Epogen, J&J’s Procrit Boost Heart Attack Patients’ Risk
Bloomberg

News

Analysts say current Medicare policy on anemia drugs is best scenario for Amgen
Yahoo/AP

News

Amgen Rises On Medicare’s Decision Not To Decide
Forbes

News

FDA may limit anemia drug use for kidney disease
Yahoo/AP
»

News

Amgen recalls anemia drugs due to glass flakes
Yahoo/AP
»

News

J&J on Hook for "Hundreds of Millions" Over Technicality in Anemia Drug Case
BNET Pharma
»